{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T09:56:40Z","timestamp":1696931800106},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.neuropharm.2003.10.012","type":"journal-article","created":{"date-parts":[[2004,1,23]],"date-time":"2004-01-23T10:18:16Z","timestamp":1074853096000},"page":"511-518","source":"Crossref","is-referenced-by-count":4,"title":["5-HT has contrasting effects in the frontal cortex, but not the hypothalamus, on changes in noradrenaline efflux induced by the monoamine releasing-agent, d-amphetamine, and the reuptake inhibitor, BTS 54 354"],"prefix":"10.1016","volume":"46","author":[{"given":"Sandrine M.","family":"G\u00e9ranton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Heal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.Clare","family":"Stanford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2003.10.012_BIB1","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s002100000294","article-title":"Interaction of the antidepressant mirtazapine with \u03b12-adrenoceptors modulating the release of 5-HT in different rat brain regions in vivo","volume":"362","author":"Bengtsson","year":"2000","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB2","first-page":"852","article-title":"Differences in modulation of noradrenergic and serotonergic transmission by the alpha2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan","volume":"277","author":"de Boer","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB3","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1523\/JNEUROSCI.14-08-04839.1994","article-title":"Dopaminergic regulation of the serotonergic raphe-striatal pathway microdialysis studies in freely-moving rats","volume":"14","author":"Ferre","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB4","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/syn.890020509","article-title":"Modified coeruleo-cortical noradrenergic neurotransmission after serotonin depletion by PCPA: electrophysiological studies in the rat","volume":"2","author":"Ferron","year":"1988","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB5","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/sj.bjp.0705396","article-title":"Differences in the mechanisms that increase noradrenaline efflux after administration of d-amphetamine: a dual-probe microdialysis study in the rat frontal cortex and hypothalamus","volume":"139","author":"G\u00e9ranton","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0028-3908(98)00188-9","article-title":"Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats","volume":"38","author":"Gobert","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0306-4522(97)00565-4","article-title":"Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release","volume":"84","author":"Gobert","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB8","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0028-3908(87)90057-8","article-title":"Evolving concepts on the interactions between antidepressant treatments and monoamine neurotransmitters","volume":"26","author":"Green","year":"1987","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1476-5381.1983.tb11063.x","article-title":"Increased 5-HT2 receptor number in brain as a probable explanation for the enhanced 5-hydroxytryptamine-mediated behaviour following repeated electroconvulsive shock administration to rats","volume":"80","author":"Green","year":"1983","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB10","first-page":"581","article-title":"In vivo criteria to differeentiate monoamine reuptake from releasing agents: sibutramine is a reuptake inhibitor","volume":"283","author":"Gundlah","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB11","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.bjp.0700968","article-title":"Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine system","volume":"120","author":"Haddjeri","year":"1997","journal-title":"Br. J. Pharmacol."},{"issue":"suppl. 10","key":"10.1016\/j.neuropharm.2003.10.012_BIB12","first-page":"3","article-title":"The pharmacology of sibutramine, the first serotonin and noradrenaline reuptake inhibitor to be developed for the treatment of obesity","volume":"11","author":"Heal","year":"1997","journal-title":"La lettre du pharmacologue"},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/sj.bjp.0702067","article-title":"A comparison of the effects on central 5-HT function of sibutramine hydrochloride and other weight-modifying agents","volume":"125","author":"Heal","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB14","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1523\/JNEUROSCI.18-06-01979.1998","article-title":"Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter","volume":"18","author":"Jones","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB15","first-page":"499","article-title":"p-Chlorophenylalanine: a specific depletor of brain serotonin","volume":"154","author":"Koe","year":"1966","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB16","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1523\/JNEUROSCI.15-02-01308.1995","article-title":"Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral response to the stereoisomers of amphetamine and methamphetamine","volume":"15","author":"Kuczenski","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-2999(94)90012-4","article-title":"Clozapine inhibits serotoninergic transmission by an action at alpha1-adrenoceptors not at 5-HT1A receptors","volume":"260","author":"Lejeune","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB18","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0028-3908(00)00041-1","article-title":"Inhibition of 5-hydroxytryptamine reuptake by the antidepressant citalopram in the locus coeruleus modulates the rat brain noradrenergic transmission in vivo","volume":"39","author":"Mateo","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB19","first-page":"1044","article-title":"Modulation of norepinephrine release by serotonergic receptors in the rat hippocampus as measured by in vivo microdialysis","volume":"272","author":"Matsumoto","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB20","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/BF00510140","article-title":"Noradrenaline inhibits central serotonin release through alpha2-adrenoceptors located on serotonergic nerve terminals","volume":"320","author":"Maura","year":"1982","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0006-8993(02)02542-8","article-title":"Effects of catecholamine uptake inhibitors in the caudate-putamen and subregions of the medial prefrontal cortex of the rat","volume":"936","author":"Mazei","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s002130050043","article-title":"A microdialysis study of the noradrenergic response in rat frontal cortex and hypothalamus to a conditioned cue for aversive, naturalistic environmental stimuli","volume":"148","author":"McQuade","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB23","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3758\/BF03326519","article-title":"Regulation of noradrenergic neuronal activity in the rat locus coeruleus by serotoninergic afferents","volume":"13","author":"McRae-Degueurce","year":"1985","journal-title":"Physiological Psychology"},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB24","series-title":"The design of experiments","author":"Mead","year":"1988"},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB25","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0028-3908(98)00078-1","article-title":"Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo","volume":"37","author":"Millan","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/026988110001400202","article-title":"Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents","volume":"14","author":"Millan","year":"2000","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB27","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1476-5381.1991.tb12261.x","article-title":"Effect of p-chlorophenylalanine on release of 5-hydroxytryptamine from the rat frontal cortex in vivo","volume":"102","author":"O\u2019Connell","year":"1991","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB28","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0031-9384(88)90325-3","article-title":"Hypothalamic infusion of amphetamine increases serotonin, dopamine and norepinephrine","volume":"44","author":"Parada","year":"1988","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB29","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB30","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1046\/j.1471-4159.1999.0731051.x","article-title":"Fluoxetine increases extracellular dopamine in the prefrontal cortex by a mechanism not dependent on serotonin: a comparison with citalopram","volume":"73","author":"Pozzi","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/syn.10245","article-title":"Regulation of the release of serotonin in the dorsal reaphe nucleus by alpha1 and alpha2 adrenoceptors","volume":"50","author":"Pudovkina","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB32","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1476-5381.1992.tb13421.x","article-title":"Subclassification of release-regulating alpha2-autoreceptors in human brain cortex","volume":"107","author":"Raiteri","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB33","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/BF00965591","article-title":"Effects of p-chlorophenylalanine on cortical monoamines and on electrical activity of noradrenergic neurons","volume":"11","author":"Reader","year":"1986","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0014-2999(94)90300-X","article-title":"\u03b11-Adrenoceptor antagonists differentially control serotonin release in the hippocampus and striatum: a microdialysis study","volume":"261","author":"Rouquier","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1098-2396(200011)38:2<167::AID-SYN8>3.0.CO;2-W","article-title":"Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats","volume":"38","author":"Rowley","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB36","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1124\/jpet.300.3.932","article-title":"Endogenous opioids in dopaminergic cell body regions modulate amphetamine-induced increases in extracellular dopamine levels in the terminal regions","volume":"300","author":"Schad","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB37","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0006-8993(93)90011-B","article-title":"Sensory responsiveness of brain noradrenergic neurons is modulated by endogenous brain serotonin","volume":"623","author":"Shiekhattar","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB38","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1476-5381.1995.tb14990.x","article-title":"Increase in noradrenaline release in the hypothalamus of freely-moving rat by postsynaptic 5-hydroxytryptamine1A receptor activation","volume":"115","author":"Suzuki","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB39","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0149-7634(96)00022-X","article-title":"Multiple serotonin receptors: too many, not enough, or just the right number?","volume":"21","author":"Uphouse","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB40","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.bjp.0702859","article-title":"Modulation of sibutramine induced increases in extracellular noradrenaline concetration in rat frontal cortex and hypothalamus","volume":"128","author":"Wortley","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB41","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1046\/j.1471-4159.1998.71010274.x","article-title":"Regulation of extracellular dopamine by the norepinephrine transporter","volume":"71","author":"Yamamoto","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2003.10.012_BIB42","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF00241089","article-title":"Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats","volume":"350","author":"Yan","year":"1994","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390803004155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390803004155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T11:59:01Z","timestamp":1550231941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390803004155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0028390803004155"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2003.10.012","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}